Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors

Abstract

Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease characterized by the occurrences of parathyroid tumors and ossifying fibroma of maxilla/mandible. It is caused by mutations in CDC73 gene and mutation carriers are at increased risk of parathyroid carcinoma. Hyperparathyroidism could be the sole manifestation. We reported two Chinese patients having parathyroid neoplasm with equivocal malignant potential and parathyroid carcinoma respectively with both germline and somatic CDC73 mutations detected. Both of them presented with severe hypercalcemia and primary hyperparathyroidism with no other HPT-JT associated tumors and negative family history. We identified one novel germline mutation CDC73 NM-024529.4: c.1475G[A; NP-078 805.3: p.Trp492X and one novel somatic mutation CDC73 NM-024529.4: c.142G[T; NP-078805.3: p.Glu48X. The other germline mutation CDC73 NM-024529.4: c.226C [T; NP-078805.3: p.Arg76X and somatic mutation CDC73 NM-024529.4: c.85delG; NP-078805.3: p.Glu29SerfsX8 were previously reported. This is the first report of CDC73 mutations in the Chinese population. Genetic analysis is reliable to confirm the underlying hereditary basis of hyperparathyroidism. By identification of mutations, the patient and the family members could benefit from regular surveillance for early detection of tumors. © 2011 Springer Science+Business Media B.V.